NCT00557011: NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD |
|
|
| Completed | 2 | 52 | US | NRP104, lisdexamfetamine dimesylate, Adderall XR, mixed salts of a single-entity amphetamine, Placebo | New River Pharmaceuticals | Attention Deficit Disorder With Hyperactivity | | 12/04 | | |